Post-exposure prophylaxis to prevent HIV: new drugs, new approaches, and more questions.

Mayer, Kenneth H; Allan-Blitz, Lao-Tzu

Mayer, Kenneth H; Allan-Blitz, Lao-Tzu.

Affiliation

Mayer KH; The Fenway Institute, Fenway Health, Boston, MA, USA; Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: kmayer@fenwayhealth.org.
Allan-Blitz LT; Division of Global Health Equity, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.

Lancet HIV ; 10(12): e816-e824, 2023 12.

Article in En | MEDLINE | ID: mdl-37952551

Subject(s)

Anti-HIV Agents; HIV Infections; Pre-Exposure Prophylaxis; Humans; HIV Infections/prevention & control; HIV Infections/drug therapy; Post-Exposure Prophylaxis; Tenofovir/therapeutic use; Emtricitabine/therapeutic use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: HIV Infections / Anti-HIV Agents / Pre-Exposure Prophylaxis Limits: Humans Language: En Journal: Lancet HIV Year: 2023 Document type: Article Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google